Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Pro-inflammatory mediators and apoptosis correlate to rt-PA response in a novel mouse model of thromboembolic stroke.

Ansar S, Chatzikonstantinou E, Thiagarajah R, Tritschler L, Fatar M, Hennerici MG, Meairs S.

PLoS One. 2014 Jan 20;9(1):e85849. doi: 10.1371/journal.pone.0085849. eCollection 2014.

2.

Characterization of a new model of thromboembolic stroke in C57 black/6J mice.

Ansar S, Chatzikonstantinou E, Wistuba-Schier A, Mirau-Weber S, Fatar M, Hennerici MG, Meairs S.

Transl Stroke Res. 2014 Aug;5(4):526-33. doi: 10.1007/s12975-013-0315-9. Epub 2013 Dec 19.

3.
5.

Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.

Romanos E, Planas AM, Amaro S, Chamorro A.

J Cereb Blood Flow Metab. 2007 Jan;27(1):14-20. Epub 2006 Apr 5.

6.

TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.

Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.

Exp Neurol. 2015 Apr;266:120-6. doi: 10.1016/j.expneurol.2015.02.013. Epub 2015 Feb 20.

PMID:
25708985
7.

Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.

El Amki M, Lerouet D, Coqueran B, Curis E, Orset C, Vivien D, Plotkine M, Marchand-Leroux C, Margaill I.

Exp Neurol. 2012 Dec;238(2):138-44. doi: 10.1016/j.expneurol.2012.08.005. Epub 2012 Aug 19.

PMID:
22921458
8.

Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.

Pfeilschifter W, Kashefiolasl S, Lauer A, Steinmetz H, Foerch C.

Neuroscience. 2013 Oct 10;250:181-8. doi: 10.1016/j.neuroscience.2013.07.003. Epub 2013 Jul 13.

PMID:
23856067
9.

Altered gene expression in an embolic stroke model after thrombolysis with tissue plasminogen activator and Stachybotrys microspora triprenyl phenol-7.

Hashimoto T, Shibata K, Ohata H, Hasumi K, Honda K.

J Pharmacol Sci. 2014;125(1):99-106. Epub 2014 May 1.

10.

Mouse model of in situ thromboembolic stroke and reperfusion.

Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D.

Stroke. 2007 Oct;38(10):2771-8. Epub 2007 Aug 16.

11.

Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.

Orbe J, Barrenetxe J, Rodriguez JA, Vivien D, Orset C, Parks WC, Birkland TP, Serrano R, Purroy A, Martinez de Lizarrondo S, Angles-Cano E, Páramo JA.

Circulation. 2011 Dec 20;124(25):2909-19. doi: 10.1161/CIRCULATIONAHA.111.047100. Epub 2011 Nov 21.

12.

Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.

Furuichi Y, Maeda M, Matsuoka N, Mutoh S, Yanagihara T.

Exp Neurol. 2007 Mar;204(1):138-46. Epub 2006 Dec 13.

PMID:
17169359
13.

Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.

Li YH, Li MH, Zhao ZG, Bai QK.

Neurol India. 2009 Jul-Aug;57(4):426-33. doi: 10.4103/0028-3886.55615.

14.

Role of tissue-type plasminogen activator in ischemic stroke.

Suzuki Y.

J Pharmacol Sci. 2010;113(3):203-7. Epub 2010 Jun 29. Review.

15.

Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.

Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, Watson T, Goyal M, Demchuk AM.

Stroke. 2010 Oct;41(10):2254-8. doi: 10.1161/STROKEAHA.110.592535. Epub 2010 Sep 9.

16.
17.

Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.

Houng AK, Wang D, Reed GL.

Exp Neurol. 2014 May;255:56-62. doi: 10.1016/j.expneurol.2014.02.009. Epub 2014 Feb 18.

18.

Combined X-ray angiography and diffusion-perfusion MRI for studying stroke evolution after rt-PA treatment in rats.

Busch E, Beaulieu C, de Crespigny A, Kreischer S, Diener HC, Moseley ME.

Brain Res. 2002 Oct 25;953(1-2):112-8.

PMID:
12384244
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk